Skip to content

The screening of high-risk groups for ovarian cancer based on the mathematical model with dynamic change of HE4 and CA125 level

The screening of high-risk groups for ovarian cancer based on the mathematical model with dynamic change of HE4 and CA125 level

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDT-12003056
Enrollment
Unknown
Registered
2012-11-11
Start date
2013-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ovarian cancer

Interventions

Gold Standard:
Index test:

Sponsors

Gynecologic Oncology Center, Peking University People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. People who is above 45 years old and has signed on the informed consent; 2. The first or second degree consanguinity of ovarian cancer patients; 3. The first or second degree consanguinity of breast cancer(detected before 50 years old) patients; 4. The first or second degree consanguinity of colon cancer patients; 5. The first or second degree consanguinity of endometrial cancer patients; 6. The first or second degree consanguinity of Primary peritoneal cancer or fallopian tube cancer patients.

Exclusion criteria

Exclusion criteria: 1. People with uterus or bilateral ovary excised; 2. People diagnosed as ovarian cancer or matastatic malignant peritoneal tumor and now in treatment; 3. People diagnosed as other cancer and need treatment now; 4. People who has undergone treatment for matastatic malignant tumor during the past 5 years; 5. Female who has mental or psychological abnomality; 6. People who is suffering some diseases with possible blood transfusion risks, for example,blood diseases like hemophilia, severe anemia, chronic infectious diseases.

Design outcomes

Primary

MeasureTime frame
CA125;HE4;

Countries

China

Contacts

Public ContactCui Heng
Cuiheng20@163.com+86 10 88324472

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026